Veracyte, Inc.
VCYT
$58.58
$1.823.21%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 166.31% | 174.89% | 427.11% | 148.73% | 148.48% |
| Total Depreciation and Amortization | -7.52% | -8.71% | -4.98% | -8.02% | -11.02% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 20.81% | 3.08% | -1.83% | -36.45% | -52.33% |
| Change in Net Operating Assets | 110.74% | 93.23% | 31.54% | -0.37% | 23.56% |
| Cash from Operations | 85.81% | 81.51% | 63.70% | 85.68% | 138.92% |
| Capital Expenditure | 1.39% | 14.26% | -4.10% | 7.01% | 1.17% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -100.00% | -100.00% | -100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 28.31% | 106.63% | -- | -- | -- |
| Cash from Investing | 23.09% | 83.64% | -1,150.70% | -1,988.71% | -1,722.18% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -30.72% | -29.57% | -25.21% | 138.87% | 132.90% |
| Repurchase of Common Stock | -12.40% | -72.86% | -112.26% | -98.50% | -95.37% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -509.92% | -186.09% | -185.33% | -959.17% | -348.61% |
| Foreign Exchange rate Adjustments | 342.56% | 269.58% | 11.68% | 900.00% | -4,940.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 442.27% | 430.43% | -41.45% | -135.24% | -171.15% |